drug resistance

A paid biotech intelligence brief on EGFR TKI resistance in NSCLC, covering osimertinib resistance mechanisms, competitive pipeline updates, and sequencing strategy. The page shows a downloadable report, pricing, publication timing, and a detailed summary of the brief’s findings.